—
C+
C+ The full Closelook — membership. Open the C+ overview

Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Technical state

As of 2026-09-18 — re-computed nightly across the coverage universe. Closelook diary readings, not advice.

Uptrend stack intact

Trades +4.9% vs the 50-day and +28% vs the 200-day average, 2.9% below the 52-week high and +97.2% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the AMRX chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-09-18

Quick answers

What is the current Closelook signal on AMRX?

Uptrend stack intact — Trades +4.9% vs the 50-day and +28% vs the 200-day average, 2.9% below the 52-week high and +97.2% off the 52-week low. Computed from daily closes. As of 2026-09-18; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is AMRX above its 50-day and 200-day moving averages?

As of 2026-09-18, Amneal Pharmaceuticals, Inc. Class A Common Stock trades +4.9% above its 50-day and +28% above its 200-day average, with the 20-day +6.1% away.

How far is AMRX from its 52-week high?

2.9% below the 52-week high and 97.2% above the 52-week low, as of 2026-09-18.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.